Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

460
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
460
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

645
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
645

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

STRIDE study post hoc analysis shows first-line mechanical aspiration thrombectomy for either in-stent or in-graft versus native vessel thrombosis in lower extremity acute limb ischemia yields similar outcomes.

Journal of vascular surgery·2025
Same author

One-year limb salvage and quality of life following mechanical aspiration thrombectomy in patients with acute lower extremity ischemia.

Journal of vascular surgery·2024
Same author

Safety and efficacy of mechanical aspiration thrombectomy for patients with acute lower extremity ischemia.

Journal of vascular surgery·2023
Same author

Prolonged lower extremity endovascular procedures for patients with claudication increase risk of adverse outcomes.

Journal of vascular surgery·2022
Same author

Contemporary Outcomes After Partial Resection of Infected Aortic Grafts.

Annals of vascular surgery·2021
Same author

Repeated Endovascular Interventions Are Worthwhile, Even After Thrombosis, to Maintain Long-Term Use of Autogenous Dialysis Fistulas.

Vascular and endovascular surgery·2021
Same journal

Prosthetic valve thrombosis: contemporary concepts in diagnosis and management.

Expert review of cardiovascular therapy·2026
Same journal

Life's essential 8 and its role in cardiovascular health: evolution, evidence, and future directions.

Expert review of cardiovascular therapy·2026
Same journal

Efficacy and safety of clopidogrel and aspirin initiated within 72 hours after mild ischemic stroke or high-risk TIA by sex: a prespecified subgroup analysis of the INSPIRES trial.

Expert review of cardiovascular therapy·2026
Same journal

Approaches to transcatheter aortic valve replacement failure: is more focus on prevention required?

Expert review of cardiovascular therapy·2026
Same journal

Vericiguat for heart failure with reduced ejection fraction: a perspective from approval to real-world clinical treatment.

Expert review of cardiovascular therapy·2026
Same journal

Early autonomic neuropathy in prediabetes: an overlooked driver of cardiometabolic risk.

Expert review of cardiovascular therapy·2026
See all related articles

Related Experiment Video

Updated: Mar 26, 2026

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

3.7K

Pharmacomechanical thrombectomy: 2015 update.

Stuart Blackwood1, Alan M Dietzek1

  • 1a Department of Vascular Surgery , Danbury Hospital Connecticut , Danbury , CT , USA.

Expert Review of Cardiovascular Therapy
|January 29, 2016
PubMed
Summary
This summary is machine-generated.

Pharmacomechanical Thrombectomy (PMT) offers a new approach for treating lower extremity deep venous thrombosis (DVT). This review examines the growing evidence for PMT compared to traditional treatments like anticoagulation.

Keywords:
Pharmacomechanical thrombectomydeep vein thrombosispostthrombotic syndromethrombolysisthrombus

More Related Videos

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

22.5K
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

3.2K

Related Experiment Videos

Last Updated: Mar 26, 2026

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

3.7K
Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

22.5K
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

3.2K

Area of Science:

  • Vascular Surgery
  • Interventional Radiology
  • Cardiovascular Medicine

Background:

  • Lower extremity deep venous thrombosis (DVT) is commonly treated with anticoagulation or compression therapy.
  • Emerging evidence suggests advanced interventional techniques may offer superior outcomes.
  • Pharmacomechanical Thrombectomy (PMT) represents a significant advancement in DVT treatment.

Purpose of the Study:

  • To review the current evidence supporting Pharmacomechanical Thrombectomy (PMT) for lower extremity DVT.
  • To compare the benefits of PMT against catheter-directed thrombolysis and anticoagulation.
  • To describe the characteristics, mechanisms, and side effects of available PMT devices.

Main Methods:

  • Literature review of studies on Pharmacomechanical Thrombectomy (PMT).
  • Analysis of evidence comparing PMT with anticoagulation and catheter-directed thrombolysis.
  • Description of device-specific features and potential adverse events.

Main Results:

  • Growing evidence, largely from case series, supports PMT for lower extremity DVT.
  • PMT may offer distinct benefits over traditional anticoagulation.
  • Understanding device-specific mechanisms and risks is crucial for optimal application.

Conclusions:

  • Pharmacomechanical Thrombectomy (PMT) is an evolving treatment modality for lower extremity DVT.
  • Further comparative studies are needed to solidify its role.
  • PMT devices have unique characteristics influencing their clinical application and safety profile.